卖什么
Turns scientific and regulatory knowledge into auditable workflows.
商业模式拆解
买家：谁掌握预算？
未核实Regulatory affairs, medical writing, clinical, safety and market-access teams at pharma, medtech, cosmetics and nutrition firms.
触发点：什么让他们现在购买？
Fragmented evidence slowing regulated deliverables, manual error-prone workflows, and need for audit-ready AI traceability.
工作流：什么输入变成什么输出？
Governed AI workflows for document co-authoring, regulatory monitoring, safety signal triage, literature review and batch record QC, each with an evidence trail.
经济账：省了什么，怎么收费？
Claims 2-50x faster task completion; commercial model not shown.
渠道：怎么接触到客户？
Direct sales ("Talk to an expert" CTAs).
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| 2026-09-22 | A 轮 | €30M | — | biolevate.com |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读，不是已确认的事实；未知之处留空，不作猜测。 更新于 2026-10-12.